Results 191 to 200 of about 100,739 (255)

Safety and Efficacy of a Paclitaxel-Coated Balloon for the Treatment of Symptomatic Patients with Long Superficial Femoral Artery Disease. [PDF]

open access: yesVasc Health Risk Manag
Sbarzaglia P   +9 more
europepmc   +1 more source

From Mechanisms to Management: Tackling In-Stent Restenosis in the Drug-Eluting Stent Era. [PDF]

open access: yesCurr Cardiol Rep
Spadafora L   +9 more
europepmc   +1 more source

Finding Safe Haven for a Migrated Left Main Coronary Stent: A Novel Bail Out Technique. [PDF]

open access: yesJACC Case Rep
Farooqui A   +4 more
europepmc   +1 more source

Peculiarities of in-Stent Thrombosis and Restenosis in Coronary Arteries Post-COVID-19: A Systematic Review of Clinical Cases and Case Series. [PDF]

open access: yesOpen Access Emerg Med
Pivina L   +8 more
europepmc   +1 more source

Assessment of Paclitaxel Drug-Coated Balloon-Only Angioplasty for Stent Thrombosis: SPARTAN-ST Study. [PDF]

open access: yesJ Cardiovasc Dev Dis
Merinopoulos I   +14 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Coronary balloon angioplasty, stents, and scaffolds

The Lancet, 2017
Since the first coronary angioplasty on Sept 16, 1977, the field of percutaneous coronary intervention has evolved rapidly. Now marking its 40th anniversary, percutaneous coronary intervention has become one of the most common medical procedures worldwide.
Robert A. Byrne   +3 more
openaire   +3 more sources

Kissing balloon coronary angioplasty

The American Journal of Cardiology, 1984
Balloon angioplasty of stenoses involving a bifurcation of coronary arteries carries a significant risk of permanent occlusion of I of the branches. 1 Kissing balloon angioplasty was first described for aortoplasty in the Leriche syndrome. 2 In 1981, Gruentzig introduced it into coronary angioplasty.
B. Meier
openaire   +4 more sources

Home - About - Disclaimer - Privacy